Form 4: Health Catalyst GC Sells Shares for Tax Obligations

Health Catalyst's General Counsel, Benjamin Landry, disposed of 20,838 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Benjamin Landry, General Counsel of Health Catalyst, Inc. (HCAT), reported a disposition of common stock.
• On March 2, 2026, 20,838 shares of common stock were sold at a price of $1.6599 per share.
• This transaction was a 'sell to cover' to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• The sale was mandated by Health Catalyst's equity incentive plans and was not a discretionary trade by Mr. Landry.
• Following this transaction, Mr. Landry beneficially owns 378,318 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine, non-discretionary transaction to cover tax obligations from RSU vesting, which is common for executives receiving equity compensation.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine occurrence for executives receiving equity compensation, particularly Restricted Stock Units (RSUs), as a mechanism to fund tax liabilities upon vesting. This type of transaction is generally not indicative of management's sentiment towards the company's future prospects but rather a standard administrative process.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and not a signal of insider sentiment or a significant change in ownership structure.

Key Dates

Recommendation

This Form 4 filing details a routine 'sell to cover' transaction by an insider to satisfy tax obligations related to RSU vesting. Such transactions are non-discretionary and do not typically reflect a change in the insider's view of the company's prospects. Therefore, it provides no new fundamental information to warrant a change in investment recommendation, and a 'hold' stance is appropriate based solely on this filing.

Keywords

Health Catalyst, HCAT, Form 4, Insider Transaction, Sell to Cover, Restricted Stock Units, RSU Vesting, Benjamin Landry